This inventor holds 1 USPTO granted patent. Top assignee: Children's Medical Center Corporation. Active years: 2008.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2008
Title: Deijan Ren: Innovator in Sperm-Specific Cation Channels
Introduction
Deijan Ren is a notable inventor based in Wynnewood, PA (US). He has made significant contributions to the field of reproductive biology through his innovative research and patenting efforts. His work focuses on the CatSper2 protein, which plays a crucial role in sperm function.
Latest Patents
Deijan Ren holds a patent titled "Sperm-specific cation channel, CatSper2, and uses therefor." This patent discloses nucleic acid and protein sequences related to the sperm-specific cation channel, CatSper2. The CatSper2 protein is specifically expressed in sperm, and the patent includes various applications such as nucleic acids, vectors, transformed cells, transgenic animals, polypeptides, and antibodies related to the CatSper2 gene and protein. Additionally, it provides methods for in vitro fertilization and contraception, identifying modulators of CatSper2 activity, genotyping subjects concerning CatSper2, and diagnosing and treating CatSper2-mediated disorders, including infertility.
Career Highlights
Deijan Ren is affiliated with the Children's Medical Center Corporation, where he continues to advance his research in reproductive health. His work has the potential to impact various aspects of fertility treatments and related medical fields.
Collaborations
Some of his notable coworkers include David Clapham and David L Garbers, who have also contributed to the research surrounding CatSper2 and its implications in reproductive biology.
Conclusion
Deijan Ren's innovative work on the CatSper2 protein and its applications in reproductive health showcases his dedication to advancing scientific knowledge and improving fertility treatments. His contributions are significant in the field and hold promise for future developments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
